Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Tiziano Prodi

Biographic Data

ID7651254
NAMETiziano Prodi
GIVEN NAMESTiziano
FAMILY NAMEProdi
SIGNATUREPRODI T
AFFILIATIONSUniversity of Milan
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2025
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Personalizing esketamine treatment in TRD and TRBD

    Open Access•Miriam Olivola, Filippo Mazzoni et al.•ARTICLE•Frontiers in Psychiatry•2026

    These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…

  • Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD

    Open Access•Vassilis Martiadis, Enrico Pessina et al.•ARTICLE•Frontiers in Psychiatry•2025

    This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings

No prominent works on this page.

  • Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD

    Open Access•Vassilis Martiadis, Enrico Pessina et al.•ARTICLE•Frontiers in Psychiatry•2025

    This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings

  • Personalizing esketamine treatment in TRD and TRBD

    Open Access•Miriam Olivola, Filippo Mazzoni et al.•ARTICLE•Frontiers in Psychiatry•2026

    These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 works) · Major depressive disorder (2 works) · Adverse effect (1 work) · Anesthesia (1 work) · Antidepressant (1 work) · Anxiety (1 work) · Cognition (1 work) · Cognitive bias (1 work) · Depression (economics (1 work) · Depressive symptoms (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae